Partners HealthCare Creates Two Investment Funds
Summary
Boston, MA-based health system Partners HealthCare has launched two new investment funds aimed at addressing the lack of translational funding in pre-clinical life sciences, Artificial Intelligence (AI) and digital technology development. The funds will support ventures that develop new drugs and technologies based on inventions originating from Partners researchers and investigators as well as companies who will work with Partners institutions to develop digital solutions. The Artificial Intelligence and Digital Translation Fund (AIDIF) which has initial funding of $30M over five years, will invest in companies that are active vendors with Partner HealthCare, creating opportunities for the “real-time lab” approach. Partners is one of the nation’s leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School. Its goal is to support medical inventions and innovations discovered by Partners HealthCare researchers and provide the appropriate guidance and infrastructure to allow technology development, commercialization and, ultimately, the development of products to benefit patients.